CompletedNot Applicable

The Taste and Acceptability of a High Protein Ice Cream Compared With Hospital Milkshake Nutritional Supplement

United Kingdom50 participantsStarted 2022-06-20

Plain-language summary

This study aims to compare the acceptability of a new high protein, fortified, ice cream called Nottingham-Ice cream (N-ICE CREAM) with a standard milkshake-style oral nutritional supplement (ONS); Fortisip Compact Protein in older patients admitted to hospital with fractures who require ONS as part of routine care.

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 65 years and over admitted to QMC hospital. * Patients capable of giving informed consent, or if appropriate, participants having a personal consultee able to complete a declaration in favour of the patient participating in the trial. * Patients with a diagnosed hip or spine fracture requiring ONS as part of the routine nutritional pathway. * Patients who have had malnutrition risk assessed by the Malnutrition Universal Screening Tool (MUST) and have a MUST score of 0 or 1. * Patients with an anticipated length of stay ≥ 4 days. Exclusion Criteria: * Patients \< 65 years old. * Patients scheduled for total parenteral nutrition or tube feeding. * Patients with a MUST ≥ 2. * Clinically unstable patients (e.g. in terminal condition end of life situation). * Patients with medical or dietary contraindication to any feed ingredients (e.g. with known allergies or intolerance to any ingredients in the N-ICE CREAM or FSCP). * Patients with significant renal impairment (chronic kidney disease stages 4 and 5). * Any contraindication against nutritional therapy (includes paralytic ileus\< inborn errors of metabolism of nutrients contained in N-ICE CREAM or FSCP).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Evaluation of acceptability by questionnaire (taste, texture, aroma, consistency etc).

Timeframe: 4 days

Evaluation of product preference

Timeframe: 4 days

Trial details

NCT IDNCT05711277

SponsorNottingham University Hospitals NHS Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Femoral Fragility Fractures trials